Prognosys Medical Systems
Founded Year
2003Stage
Corporate Majority | AcquiredTotal Raised
$33.23MAbout Prognosys Medical Systems
Prognosys Medical Systems operates as a manufacturer of radiology and telehealth devices. It offers products that are developed using new and evolved technologies, providing a wide range of patient care and healthcare products. The company designs and builds radiology and fluoroscopy solutions under the brand name Prorad. It was founded in 2003 and is based in Bengaluru, India. In February 2023, Molbio Diagnostics acquired a majority stake in Prognosys Medical Systems. The terms of the transaction were not disclosed.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Prognosys Medical Systems Patents
Prognosys Medical Systems has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/14/2009 | 5/6/2014 | Analytical chemistry, Chromatography, Immunologic tests, Mass spectrometry, Ion source | Grant |
Application Date | 8/14/2009 |
|---|---|
Grant Date | 5/6/2014 |
Title | |
Related Topics | Analytical chemistry, Chromatography, Immunologic tests, Mass spectrometry, Ion source |
Status | Grant |
Latest Prognosys Medical Systems News
Feb 24, 2023
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys. Global CGM device maker Dexcom has launched its latest CGM system in Singapore. Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device. It pairs with a companion mobile app on iOS and Android devices, enabling the sharing of glucose data with up to ten people, including families and healthcare teams. The launch of the Dexcom G6 comes after it obtained approval from the Health Sciences Authority late last year and the recent opening of the Dexcom regional headquarter in the country. Molbio takes majority stake in digital x-ray maker Prognosys Indian medical device unicorn company Molbio Diagnostics has acquired a 70% stake in Prognosys Medical Systems. Prognosys develops radiology and fluoroscopy solutions under the Prorad brand. It has recently introduced a line of digital x-ray units that offers high-quality chest imaging powered by AI. Its combination with Molbio's Truenat testing kit will enhance the diagnosis of deadly communicable and non-communicable diseases such as tuberculosis, COVID-19, and other chest-related conditions in large populations, according to Molbio. Truenat is a WHO-endorsed point-of-care PCR platform that can screen over 40 diseases within an hour. 2C2P provides payment capabilities to DKSH's patient platform The healthcare business unit of DKSH Singapore has tapped 2C2P to build new payment capabilities for its patient engagement management platform. Through this partnership, patients on DKSH's PSPhere platform can now apply for rebates, instalment plans, and e-wallets in a "secure and compliant" manner, according to a press statement. Tags:
Prognosys Medical Systems Frequently Asked Questions (FAQ)
When was Prognosys Medical Systems founded?
Prognosys Medical Systems was founded in 2003.
Where is Prognosys Medical Systems's headquarters?
Prognosys Medical Systems's headquarters is located at 249, 4th Main Road, Bengaluru.
What is Prognosys Medical Systems's latest funding round?
Prognosys Medical Systems's latest funding round is Corporate Majority.
How much did Prognosys Medical Systems raise?
Prognosys Medical Systems raised a total of $33.23M.
Who are the investors of Prognosys Medical Systems?
Investors of Prognosys Medical Systems include Molbio Diagnostics and Somerset Indus Capital Partners.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
